Skip to main content

ACE/ARB Therapy at Discharge for ICD implant patients with Left Ventricular Systolic Dysfunction

CBE ID
1522
Project
Cardiovascular
Endorsed
New or Maintenance
Maintenance
Endorsement and Maintenance (E&M) Cycle
Full Year 2015
Is Under Review
No
Measure Description

Proportion of ICD implant patients with a diagnosis of LVSD who are prescribed ACE-I or ARB therapy at discharge.

  • Measure Type
    Process
    Electronic Clinical Quality Measure (eCQM)
    No
    Level Of Analysis
    Facility
    Care Setting
    Inpatient/Hospital
    Numerator

    Count of patients with ACE-I or ARB therapy prescribed at discharge.

    Denominator

    1) Count of patients with an ICD implant with moderate or severe LVSD (LVEF<40%) who are eligible for ACE inhibitors who do not have a contraindication to ACE inhibitors documented
    AND
    2)Count of patients with an ICD implant with moderate or severe LVSD (LVEF<40%) who are eligible for ARB therapy who do not have a contraindication to ARB therapy documented

    Exclusions

    Discharge status of expired
    Contraindicated or blinded to both ACE inhibitors and ARB therapy

    Testing Data Sources
    Registry data
  • Most Recent Endorsement Activity
    Measure Retired and Endorsement Removed Cardiovascular Project 2015-2016
    Initial Endorsement
    Endorsement Status
    Endorsement Removed
    Last Updated
    Removal Date